Categories
Life Sciences Consumer Goods Materials and Chemicals Construction & Manufacturing Food and Beverages Energy and Power Semiconductor and Electronics Automotive and Transportation ICT & Media Aerospace & Defense BFSI

Int'l : +1-503-894-6022 | Toll Free : +1-800-792-5285 | help@alliedmarketresearch.com

Cold and Flu Supplements Market by Product Type (Natural Molecules, Herbal Extracts, Vitamins and Minerals) and by End User (Hospitals, Ambulatory Surgical Centers, Others): Global Opportunity Analysis and Industry Forecast, 2023-2032

A12333

Pages: NA

Charts: NA

Tables: NA

Cold and Flu Supplements Market Statistics 2030:

Cold and flu supplements are safe and effective drugs that are available at local stores and pharmacies and sold without prescription as over-the-counter medicines. The supplements contain antihistamines, cough suppressants, decongestants, and pain relievers.

Echinacea is an herbal supplement associated with the prevention and treatment of colds. This plant is endorsed as an immune system stimulant. Elderberry is commonly used for treating the flu, as it exhibits antioxidant and immune-modulating properties. Many patients take garlic as a preventative for the common cold. Both Panax ginseng and Panax quinquefolium have been evaluated for their use in upper respiratory tract infections. Vitamin C is a water-soluble vitamin that has an important role in various physiological processes. Zinc inhibits the replication of the cold virus. Owing to these effects, zinc supplements are thought to be effective in preventing and treating common cold.

COVID-19 Impact Analysis

Pharmaceutical and biotech companies together with governments around the globe are working to address the COVID-19 outbreak, from supporting the development of vaccines to planning for medicine supply chain challenges. Currently, around 115 vaccine candidates and 155 molecules are in the R&D pipeline. Moreover, commonly used drugs such as Hydroxychloroquine have witnessed a dramatic surge in demand for the management of COVID-19. Such high demand for these drugs has presented huge opportunities for manufacturers of COVID-19 management drugs, as many developed countries are facing shortage of these drugs. Thus, the pharmaceutical and biotechnology industry is expected to witness a significant growth in the future, owing to the demand for vaccine and treatment drugs for COVID-19. This, in turn, is expected to have a significant impact on the cold and flu supplements market.

Top Impacting Factors

  • Changing lifestyle along with easy access to supplements through offline and online stores has been generating demand for cold and flu supplements.
  • Furthermore, improving buyers’ knowledge about the medicinal properties of several natural ingredients is driving the demand for cold and flu supplements.
  • Moreover, increasing purchasing power of the consumers is projected to raise the spending on cold and flu supplements.
  • To boost immunity and prevent the occurrences of diseases, the demand cold and flu supplements have been increasing among consumers.
  • The growing government’s supports to offer free flu immunization is propelling the growth of the cold and flu supplements market.
  • Moreover, the growing aging population all across the globe is likely to boost the global market growth during the forecast period.

Market Trends

New product launches to flourish the market

June 09, 2020 Rapid Nutrition has been awarded an Innovation Connections grant to further develop and commercialize the formula. Sponsored by the Australian Government, the grant will facilitate a partnership between Rapid Nutrition and one of Australia’s leading universities for ongoing clinical trials.

On August 1, 2019, GSK announced that it would completed transaction with Pfizer to combine consumer healthcare businesses into a new world-leading Consumer Healthcare Joint Venture. Within three years of the closing of the transaction, it intends to separate the Joint Venture via a demerger. With future intention to separate, the transaction presents a clear pathway to create a new global pharmaceuticals/vaccines company, and a new world-leading consumer healthcare company.

Surge in usage to enhance immunity

Products or supplements categorized with natural and immunity-boosting claims have a wide opportunity among the consumers as they highlight the buyers’ requirements. The cold and flu supplements are available in different popular forms such as tablets and capsules. Product innovations and brand extensions have been leading the growth of the cold and flu supplements industry. In addition, the outbreak of COVID-19 has severely increased the sales of preventive products, such as vitamins and minerals supplements across the globe. Especially, the demand for vitamin C has been witnessing a remarkable increase.

Key Benefits of the Report

  • This study presents the analytical depiction of the cold and flu supplements along with the current trends and future estimations to determine the imminent investment pockets.
  • The report presents information related to key drivers, restraints, and opportunities along with detailed analysis of the market share.
  • The current market is quantitatively analyzed to highlight the market growth scenario.
  • Porter’s five forces analysis illustrates the potency of buyers & suppliers in the market.
  • The report provides a detailed market analysis depending on competitive intensity and how the competition will take shape in coming years.

Questions Answered in the Cold and Flu Supplements Report

  • Which are the leading players active in the cold and flu supplements market?
  • What are current trends that will influence the market in the next few years?
  • What are the driving factors, restraints, and opportunities of the market?
  • What future projections would help in taking further strategic steps?
  • What is "Cold and Flu Supplements "?
  • What is "Cold and Flu Supplements” Market prediction in the future?
  • Who are the leading global players in the "Cold and Flu Supplements” Market?
  • What are the current trends and predicted trends?
  • What are the key benefits of the "Cold and Flu Supplements” Market report?

 Key Market Segments

  • By Product Type
    • Natural Molecules
    • Herbal Extracts
    • Vitamins and Minerals
  • By End User
    • Hospitals
    • Ambulatory Surgical Centers
    • Others
  • By Region
    • North America
      • U.S.
      • Canada
      • Mexico
    • Europe
      • France
      • Germany
      • Italy
      • Spain
      • UK
      • Rest of Europe
    • Asia-Pacific
      • China
      • Japan
      • India
      • South Korea
      • Australia
      • Rest of Asia-Pacific
    • LAMEA
      • Brazil
      • South Africa
      • Saudi Arabia
      • Rest of LAMEA

 
Key Market Players

  • klaire labs
  • Neurobiologix Inc.
  • FineVine, Flora Inc.
  • Nature's Way Products, LLC
  • Himalaya Global Holdings Ltd.
  • Wakunaga of America co., Ltd.
  • Pfizer Inc.
  • Nordic Naturals
  • GlaxoSmithKline Plc
  • The Vitamin Shoppe

  • CHAPTER 1: INTRODUCTION

    • 1.1. Report Description

    • 1.2. Key Market Segments

    • 1.3. Key Benefits

    • 1.4. Research Methodology

      • 1.4.1. Primary Research

      • 1.4.2. Secondary Research

      • 1.4.3. Analyst Tools and Models

  • CHAPTER 2: EXECUTIVE SUMMARY

    • 2.1. CXO Perspective

  • CHAPTER 3: MARKET LANDSCAPE

    • 3.1. Market Definition and Scope

    • 3.2. Key Findings

      • 3.2.1. Top Investment Pockets

      • 3.2.2. Top Winning Strategies

    • 3.3. Porter's Five Forces Analysis

      • 3.3.1. Bargaining Power of Suppliers

      • 3.3.2. Threat of New Entrants

      • 3.3.3. Threat of Substitutes

      • 3.3.4. Competitive Rivalry

      • 3.3.5. Bargaining Power among Buyers

    • 3.5. Market Dynamics

      • 3.5.1. Drivers

      • 3.5.2. Restraints

      • 3.5.3. Opportunities

  • CHAPTER 4: COLD AND FLU SUPPLEMENTS MARKET, BY PRODUCT TYPE

    • 4.1. Market Overview

      • 4.1.1 Market Size and Forecast, By Product Type

    • 4.2. Natural Molecules

      • 4.2.1. Key Market Trends, Growth Factors and Opportunities

      • 4.2.2. Market Size and Forecast, By Region

      • 4.2.3. Market Share Analysis, By Country

    • 4.3. Herbal Extracts

      • 4.3.1. Key Market Trends, Growth Factors and Opportunities

      • 4.3.2. Market Size and Forecast, By Region

      • 4.3.3. Market Share Analysis, By Country

    • 4.4. Vitamins And Minerals

      • 4.4.1. Key Market Trends, Growth Factors and Opportunities

      • 4.4.2. Market Size and Forecast, By Region

      • 4.4.3. Market Share Analysis, By Country

  • CHAPTER 5: COLD AND FLU SUPPLEMENTS MARKET, BY END USER

    • 5.1. Market Overview

      • 5.1.1 Market Size and Forecast, By End User

    • 5.2. Hospitals

      • 5.2.1. Key Market Trends, Growth Factors and Opportunities

      • 5.2.2. Market Size and Forecast, By Region

      • 5.2.3. Market Share Analysis, By Country

    • 5.3. Ambulatory Surgical Centers

      • 5.3.1. Key Market Trends, Growth Factors and Opportunities

      • 5.3.2. Market Size and Forecast, By Region

      • 5.3.3. Market Share Analysis, By Country

    • 5.4. Others

      • 5.4.1. Key Market Trends, Growth Factors and Opportunities

      • 5.4.2. Market Size and Forecast, By Region

      • 5.4.3. Market Share Analysis, By Country

  • CHAPTER 6: COLD AND FLU SUPPLEMENTS MARKET, BY REGION

    • 6.1. Market Overview

      • 6.1.1 Market Size and Forecast, By Region

    • 6.2. North America

      • 6.2.1. Key Market Trends and Opportunities

      • 6.2.2. Market Size and Forecast, By Product Type

      • 6.2.3. Market Size and Forecast, By End User

      • 6.2.4. Market Size and Forecast, By Country

      • 6.2.5. U.S. Cold And Flu Supplements Market

        • 6.2.5.1. Market Size and Forecast, By Product Type
        • 6.2.5.2. Market Size and Forecast, By End User

      • 6.2.6. Canada Cold And Flu Supplements Market

        • 6.2.6.1. Market Size and Forecast, By Product Type
        • 6.2.6.2. Market Size and Forecast, By End User

      • 6.2.7. Mexico Cold And Flu Supplements Market

        • 6.2.7.1. Market Size and Forecast, By Product Type
        • 6.2.7.2. Market Size and Forecast, By End User

    • 6.3. Europe

      • 6.3.1. Key Market Trends and Opportunities

      • 6.3.2. Market Size and Forecast, By Product Type

      • 6.3.3. Market Size and Forecast, By End User

      • 6.3.4. Market Size and Forecast, By Country

      • 6.3.5. France Cold And Flu Supplements Market

        • 6.3.5.1. Market Size and Forecast, By Product Type
        • 6.3.5.2. Market Size and Forecast, By End User

      • 6.3.6. Germany Cold And Flu Supplements Market

        • 6.3.6.1. Market Size and Forecast, By Product Type
        • 6.3.6.2. Market Size and Forecast, By End User

      • 6.3.7. Italy Cold And Flu Supplements Market

        • 6.3.7.1. Market Size and Forecast, By Product Type
        • 6.3.7.2. Market Size and Forecast, By End User

      • 6.3.8. Spain Cold And Flu Supplements Market

        • 6.3.8.1. Market Size and Forecast, By Product Type
        • 6.3.8.2. Market Size and Forecast, By End User

      • 6.3.9. UK Cold And Flu Supplements Market

        • 6.3.9.1. Market Size and Forecast, By Product Type
        • 6.3.9.2. Market Size and Forecast, By End User

      • 6.3.10. Russia Cold And Flu Supplements Market

        • 6.3.10.1. Market Size and Forecast, By Product Type
        • 6.3.10.2. Market Size and Forecast, By End User

      • 6.3.11. Rest Of Europe Cold And Flu Supplements Market

        • 6.3.11.1. Market Size and Forecast, By Product Type
        • 6.3.11.2. Market Size and Forecast, By End User

    • 6.4. Asia-Pacific

      • 6.4.1. Key Market Trends and Opportunities

      • 6.4.2. Market Size and Forecast, By Product Type

      • 6.4.3. Market Size and Forecast, By End User

      • 6.4.4. Market Size and Forecast, By Country

      • 6.4.5. China Cold And Flu Supplements Market

        • 6.4.5.1. Market Size and Forecast, By Product Type
        • 6.4.5.2. Market Size and Forecast, By End User

      • 6.4.6. Japan Cold And Flu Supplements Market

        • 6.4.6.1. Market Size and Forecast, By Product Type
        • 6.4.6.2. Market Size and Forecast, By End User

      • 6.4.7. India Cold And Flu Supplements Market

        • 6.4.7.1. Market Size and Forecast, By Product Type
        • 6.4.7.2. Market Size and Forecast, By End User

      • 6.4.8. South Korea Cold And Flu Supplements Market

        • 6.4.8.1. Market Size and Forecast, By Product Type
        • 6.4.8.2. Market Size and Forecast, By End User

      • 6.4.9. Australia Cold And Flu Supplements Market

        • 6.4.9.1. Market Size and Forecast, By Product Type
        • 6.4.9.2. Market Size and Forecast, By End User

      • 6.4.10. Thailand Cold And Flu Supplements Market

        • 6.4.10.1. Market Size and Forecast, By Product Type
        • 6.4.10.2. Market Size and Forecast, By End User

      • 6.4.11. Malaysia Cold And Flu Supplements Market

        • 6.4.11.1. Market Size and Forecast, By Product Type
        • 6.4.11.2. Market Size and Forecast, By End User

      • 6.4.12. Indonesia Cold And Flu Supplements Market

        • 6.4.12.1. Market Size and Forecast, By Product Type
        • 6.4.12.2. Market Size and Forecast, By End User

      • 6.4.13. Rest of Asia Pacific Cold And Flu Supplements Market

        • 6.4.13.1. Market Size and Forecast, By Product Type
        • 6.4.13.2. Market Size and Forecast, By End User

    • 6.5. LAMEA

      • 6.5.1. Key Market Trends and Opportunities

      • 6.5.2. Market Size and Forecast, By Product Type

      • 6.5.3. Market Size and Forecast, By End User

      • 6.5.4. Market Size and Forecast, By Country

      • 6.5.5. Brazil Cold And Flu Supplements Market

        • 6.5.5.1. Market Size and Forecast, By Product Type
        • 6.5.5.2. Market Size and Forecast, By End User

      • 6.5.6. South Africa Cold And Flu Supplements Market

        • 6.5.6.1. Market Size and Forecast, By Product Type
        • 6.5.6.2. Market Size and Forecast, By End User

      • 6.5.7. Saudi Arabia Cold And Flu Supplements Market

        • 6.5.7.1. Market Size and Forecast, By Product Type
        • 6.5.7.2. Market Size and Forecast, By End User

      • 6.5.8. UAE Cold And Flu Supplements Market

        • 6.5.8.1. Market Size and Forecast, By Product Type
        • 6.5.8.2. Market Size and Forecast, By End User

      • 6.5.9. Argentina Cold And Flu Supplements Market

        • 6.5.9.1. Market Size and Forecast, By Product Type
        • 6.5.9.2. Market Size and Forecast, By End User

      • 6.5.10. Rest of LAMEA Cold And Flu Supplements Market

        • 6.5.10.1. Market Size and Forecast, By Product Type
        • 6.5.10.2. Market Size and Forecast, By End User

  • CHAPTER 7: COMPETITIVE LANDSCAPE

    • 7.1. Introduction

    • 7.2. Top Winning Strategies

    • 7.3. Product Mapping Of Top 10 Player

    • 7.4. Competitive Dashboard

    • 7.5. Competitive Heatmap

    • 7.6. Top Player Positioning, 2024

  • CHAPTER 8: COMPANY PROFILES

    • 8.1. Wakunaga Of America Co., Ltd.

      • 8.1.1. Company Overview

      • 8.1.2. Key Executives

      • 8.1.3. Company Snapshot

      • 8.1.4. Operating Business Segments

      • 8.1.5. Product Portfolio

      • 8.1.6. Business Performance

      • 8.1.7. Key Strategic Moves and Developments

    • 8.2. Neurobiologix Inc.

      • 8.2.1. Company Overview

      • 8.2.2. Key Executives

      • 8.2.3. Company Snapshot

      • 8.2.4. Operating Business Segments

      • 8.2.5. Product Portfolio

      • 8.2.6. Business Performance

      • 8.2.7. Key Strategic Moves and Developments

    • 8.3. The Vitamin Shoppe

      • 8.3.1. Company Overview

      • 8.3.2. Key Executives

      • 8.3.3. Company Snapshot

      • 8.3.4. Operating Business Segments

      • 8.3.5. Product Portfolio

      • 8.3.6. Business Performance

      • 8.3.7. Key Strategic Moves and Developments

    • 8.4. Klaire Labs

      • 8.4.1. Company Overview

      • 8.4.2. Key Executives

      • 8.4.3. Company Snapshot

      • 8.4.4. Operating Business Segments

      • 8.4.5. Product Portfolio

      • 8.4.6. Business Performance

      • 8.4.7. Key Strategic Moves and Developments

    • 8.5. Nordic Naturals

      • 8.5.1. Company Overview

      • 8.5.2. Key Executives

      • 8.5.3. Company Snapshot

      • 8.5.4. Operating Business Segments

      • 8.5.5. Product Portfolio

      • 8.5.6. Business Performance

      • 8.5.7. Key Strategic Moves and Developments

    • 8.6. Himalaya Global Holdings Ltd.

      • 8.6.1. Company Overview

      • 8.6.2. Key Executives

      • 8.6.3. Company Snapshot

      • 8.6.4. Operating Business Segments

      • 8.6.5. Product Portfolio

      • 8.6.6. Business Performance

      • 8.6.7. Key Strategic Moves and Developments

    • 8.7. Nature's Way Products, LLC

      • 8.7.1. Company Overview

      • 8.7.2. Key Executives

      • 8.7.3. Company Snapshot

      • 8.7.4. Operating Business Segments

      • 8.7.5. Product Portfolio

      • 8.7.6. Business Performance

      • 8.7.7. Key Strategic Moves and Developments

    • 8.8. FineVine, Flora Inc.

      • 8.8.1. Company Overview

      • 8.8.2. Key Executives

      • 8.8.3. Company Snapshot

      • 8.8.4. Operating Business Segments

      • 8.8.5. Product Portfolio

      • 8.8.6. Business Performance

      • 8.8.7. Key Strategic Moves and Developments

    • 8.9. Pfizer Inc.

      • 8.9.1. Company Overview

      • 8.9.2. Key Executives

      • 8.9.3. Company Snapshot

      • 8.9.4. Operating Business Segments

      • 8.9.5. Product Portfolio

      • 8.9.6. Business Performance

      • 8.9.7. Key Strategic Moves and Developments

    • 8.10. GlaxoSmithKline Plc

      • 8.10.1. Company Overview

      • 8.10.2. Key Executives

      • 8.10.3. Company Snapshot

      • 8.10.4. Operating Business Segments

      • 8.10.5. Product Portfolio

      • 8.10.6. Business Performance

      • 8.10.7. Key Strategic Moves and Developments

  • LIST OF TABLES

  • TABLE 1. GLOBAL COLD AND FLU SUPPLEMENTS MARKET, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 2. GLOBAL COLD AND FLU SUPPLEMENTS MARKET FOR NATURAL MOLECULES, BY REGION, 2025-2033 ($MILLION)
  • TABLE 3. GLOBAL COLD AND FLU SUPPLEMENTS MARKET FOR HERBAL EXTRACTS, BY REGION, 2025-2033 ($MILLION)
  • TABLE 4. GLOBAL COLD AND FLU SUPPLEMENTS MARKET FOR VITAMINS AND MINERALS, BY REGION, 2025-2033 ($MILLION)
  • TABLE 5. GLOBAL COLD AND FLU SUPPLEMENTS MARKET, BY END USER, 2025-2033 ($MILLION)
  • TABLE 6. GLOBAL COLD AND FLU SUPPLEMENTS MARKET FOR HOSPITALS, BY REGION, 2025-2033 ($MILLION)
  • TABLE 7. GLOBAL COLD AND FLU SUPPLEMENTS MARKET FOR AMBULATORY SURGICAL CENTERS, BY REGION, 2025-2033 ($MILLION)
  • TABLE 8. GLOBAL COLD AND FLU SUPPLEMENTS MARKET FOR OTHERS, BY REGION, 2025-2033 ($MILLION)
  • TABLE 9. GLOBAL COLD AND FLU SUPPLEMENTS MARKET, BY REGION, 2025-2033 ($MILLION)
  • TABLE 10. NORTH AMERICA COLD AND FLU SUPPLEMENTS, BY REGION, 2025-2033 ($MILLION)
  • TABLE 11. NORTH AMERICA COLD AND FLU SUPPLEMENTS, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 12. NORTH AMERICA COLD AND FLU SUPPLEMENTS, BY END USER, 2025-2033 ($MILLION)
  • TABLE 13. U.S. COLD AND FLU SUPPLEMENTS, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 14. U.S. COLD AND FLU SUPPLEMENTS, BY END USER, 2025-2033 ($MILLION)
  • TABLE 15. CANADA COLD AND FLU SUPPLEMENTS, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 16. CANADA COLD AND FLU SUPPLEMENTS, BY END USER, 2025-2033 ($MILLION)
  • TABLE 17. MEXICO COLD AND FLU SUPPLEMENTS, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 18. MEXICO COLD AND FLU SUPPLEMENTS, BY END USER, 2025-2033 ($MILLION)
  • TABLE 19. EUROPE COLD AND FLU SUPPLEMENTS, BY REGION, 2025-2033 ($MILLION)
  • TABLE 20. EUROPE COLD AND FLU SUPPLEMENTS, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 21. EUROPE COLD AND FLU SUPPLEMENTS, BY END USER, 2025-2033 ($MILLION)
  • TABLE 22. FRANCE COLD AND FLU SUPPLEMENTS, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 23. FRANCE COLD AND FLU SUPPLEMENTS, BY END USER, 2025-2033 ($MILLION)
  • TABLE 24. GERMANY COLD AND FLU SUPPLEMENTS, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 25. GERMANY COLD AND FLU SUPPLEMENTS, BY END USER, 2025-2033 ($MILLION)
  • TABLE 26. ITALY COLD AND FLU SUPPLEMENTS, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 27. ITALY COLD AND FLU SUPPLEMENTS, BY END USER, 2025-2033 ($MILLION)
  • TABLE 28. SPAIN COLD AND FLU SUPPLEMENTS, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 29. SPAIN COLD AND FLU SUPPLEMENTS, BY END USER, 2025-2033 ($MILLION)
  • TABLE 30. UK COLD AND FLU SUPPLEMENTS, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 31. UK COLD AND FLU SUPPLEMENTS, BY END USER, 2025-2033 ($MILLION)
  • TABLE 32. RUSSIA COLD AND FLU SUPPLEMENTS, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 33. RUSSIA COLD AND FLU SUPPLEMENTS, BY END USER, 2025-2033 ($MILLION)
  • TABLE 34. REST OF EUROPE COLD AND FLU SUPPLEMENTS, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 35. REST OF EUROPE COLD AND FLU SUPPLEMENTS, BY END USER, 2025-2033 ($MILLION)
  • TABLE 36. ASIA-PACIFIC COLD AND FLU SUPPLEMENTS, BY REGION, 2025-2033 ($MILLION)
  • TABLE 37. ASIA-PACIFIC COLD AND FLU SUPPLEMENTS, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 38. ASIA-PACIFIC COLD AND FLU SUPPLEMENTS, BY END USER, 2025-2033 ($MILLION)
  • TABLE 39. CHINA COLD AND FLU SUPPLEMENTS, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 40. CHINA COLD AND FLU SUPPLEMENTS, BY END USER, 2025-2033 ($MILLION)
  • TABLE 41. JAPAN COLD AND FLU SUPPLEMENTS, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 42. JAPAN COLD AND FLU SUPPLEMENTS, BY END USER, 2025-2033 ($MILLION)
  • TABLE 43. INDIA COLD AND FLU SUPPLEMENTS, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 44. INDIA COLD AND FLU SUPPLEMENTS, BY END USER, 2025-2033 ($MILLION)
  • TABLE 45. SOUTH KOREA COLD AND FLU SUPPLEMENTS, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 46. SOUTH KOREA COLD AND FLU SUPPLEMENTS, BY END USER, 2025-2033 ($MILLION)
  • TABLE 47. AUSTRALIA COLD AND FLU SUPPLEMENTS, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 48. AUSTRALIA COLD AND FLU SUPPLEMENTS, BY END USER, 2025-2033 ($MILLION)
  • TABLE 49. THAILAND COLD AND FLU SUPPLEMENTS, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 50. THAILAND COLD AND FLU SUPPLEMENTS, BY END USER, 2025-2033 ($MILLION)
  • TABLE 51. MALAYSIA COLD AND FLU SUPPLEMENTS, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 52. MALAYSIA COLD AND FLU SUPPLEMENTS, BY END USER, 2025-2033 ($MILLION)
  • TABLE 53. INDONESIA COLD AND FLU SUPPLEMENTS, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 54. INDONESIA COLD AND FLU SUPPLEMENTS, BY END USER, 2025-2033 ($MILLION)
  • TABLE 55. REST OF ASIA PACIFIC COLD AND FLU SUPPLEMENTS, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 56. REST OF ASIA PACIFIC COLD AND FLU SUPPLEMENTS, BY END USER, 2025-2033 ($MILLION)
  • TABLE 57. LAMEA COLD AND FLU SUPPLEMENTS, BY REGION, 2025-2033 ($MILLION)
  • TABLE 58. LAMEA COLD AND FLU SUPPLEMENTS, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 59. LAMEA COLD AND FLU SUPPLEMENTS, BY END USER, 2025-2033 ($MILLION)
  • TABLE 60. BRAZIL COLD AND FLU SUPPLEMENTS, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 61. BRAZIL COLD AND FLU SUPPLEMENTS, BY END USER, 2025-2033 ($MILLION)
  • TABLE 62. SOUTH AFRICA COLD AND FLU SUPPLEMENTS, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 63. SOUTH AFRICA COLD AND FLU SUPPLEMENTS, BY END USER, 2025-2033 ($MILLION)
  • TABLE 64. SAUDI ARABIA COLD AND FLU SUPPLEMENTS, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 65. SAUDI ARABIA COLD AND FLU SUPPLEMENTS, BY END USER, 2025-2033 ($MILLION)
  • TABLE 66. UAE COLD AND FLU SUPPLEMENTS, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 67. UAE COLD AND FLU SUPPLEMENTS, BY END USER, 2025-2033 ($MILLION)
  • TABLE 68. ARGENTINA COLD AND FLU SUPPLEMENTS, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 69. ARGENTINA COLD AND FLU SUPPLEMENTS, BY END USER, 2025-2033 ($MILLION)
  • TABLE 70. REST OF LAMEA COLD AND FLU SUPPLEMENTS, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 71. REST OF LAMEA COLD AND FLU SUPPLEMENTS, BY END USER, 2025-2033 ($MILLION)
  • TABLE 72. WAKUNAGA OF AMERICA CO., LTD.: KEY EXECUTIVES
  • TABLE 73. WAKUNAGA OF AMERICA CO., LTD.: COMPANY SNAPSHOT
  • TABLE 74. WAKUNAGA OF AMERICA CO., LTD.: OPERATING SEGMENTS
  • TABLE 75. WAKUNAGA OF AMERICA CO., LTD.: PRODUCT PORTFOLIO
  • TABLE 76. WAKUNAGA OF AMERICA CO., LTD.: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 77. NEUROBIOLOGIX INC.: KEY EXECUTIVES
  • TABLE 78. NEUROBIOLOGIX INC.: COMPANY SNAPSHOT
  • TABLE 79. NEUROBIOLOGIX INC.: OPERATING SEGMENTS
  • TABLE 80. NEUROBIOLOGIX INC.: PRODUCT PORTFOLIO
  • TABLE 81. NEUROBIOLOGIX INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 82. THE VITAMIN SHOPPE: KEY EXECUTIVES
  • TABLE 83. THE VITAMIN SHOPPE: COMPANY SNAPSHOT
  • TABLE 84. THE VITAMIN SHOPPE: OPERATING SEGMENTS
  • TABLE 85. THE VITAMIN SHOPPE: PRODUCT PORTFOLIO
  • TABLE 86. THE VITAMIN SHOPPE: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 87. KLAIRE LABS: KEY EXECUTIVES
  • TABLE 88. KLAIRE LABS: COMPANY SNAPSHOT
  • TABLE 89. KLAIRE LABS: OPERATING SEGMENTS
  • TABLE 90. KLAIRE LABS: PRODUCT PORTFOLIO
  • TABLE 91. KLAIRE LABS: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 92. NORDIC NATURALS: KEY EXECUTIVES
  • TABLE 93. NORDIC NATURALS: COMPANY SNAPSHOT
  • TABLE 94. NORDIC NATURALS: OPERATING SEGMENTS
  • TABLE 95. NORDIC NATURALS: PRODUCT PORTFOLIO
  • TABLE 96. NORDIC NATURALS: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 97. HIMALAYA GLOBAL HOLDINGS LTD.: KEY EXECUTIVES
  • TABLE 98. HIMALAYA GLOBAL HOLDINGS LTD.: COMPANY SNAPSHOT
  • TABLE 99. HIMALAYA GLOBAL HOLDINGS LTD.: OPERATING SEGMENTS
  • TABLE 100. HIMALAYA GLOBAL HOLDINGS LTD.: PRODUCT PORTFOLIO
  • TABLE 101. HIMALAYA GLOBAL HOLDINGS LTD.: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 102. NATURE'S WAY PRODUCTS, LLC: KEY EXECUTIVES
  • TABLE 103. NATURE'S WAY PRODUCTS, LLC: COMPANY SNAPSHOT
  • TABLE 104. NATURE'S WAY PRODUCTS, LLC: OPERATING SEGMENTS
  • TABLE 105. NATURE'S WAY PRODUCTS, LLC: PRODUCT PORTFOLIO
  • TABLE 106. NATURE'S WAY PRODUCTS, LLC: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 107. FINEVINE, FLORA INC.: KEY EXECUTIVES
  • TABLE 108. FINEVINE, FLORA INC.: COMPANY SNAPSHOT
  • TABLE 109. FINEVINE, FLORA INC.: OPERATING SEGMENTS
  • TABLE 110. FINEVINE, FLORA INC.: PRODUCT PORTFOLIO
  • TABLE 111. FINEVINE, FLORA INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 112. PFIZER INC.: KEY EXECUTIVES
  • TABLE 113. PFIZER INC.: COMPANY SNAPSHOT
  • TABLE 114. PFIZER INC.: OPERATING SEGMENTS
  • TABLE 115. PFIZER INC.: PRODUCT PORTFOLIO
  • TABLE 116. PFIZER INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 117. GLAXOSMITHKLINE PLC: KEY EXECUTIVES
  • TABLE 118. GLAXOSMITHKLINE PLC: COMPANY SNAPSHOT
  • TABLE 119. GLAXOSMITHKLINE PLC: OPERATING SEGMENTS
  • TABLE 120. GLAXOSMITHKLINE PLC: PRODUCT PORTFOLIO
  • TABLE 121. GLAXOSMITHKLINE PLC: KEY STRATEGIC MOVES AND DEVELOPMENTS

  • LIST OF FIGURES

  • FIGURE 1. GLOBAL COLD AND FLU SUPPLEMENTS MARKET SEGMENTATION
  • FIGURE 2. GLOBAL COLD AND FLU SUPPLEMENTS MARKET
  • FIGURE 3. SEGMENTATION COLD AND FLU SUPPLEMENTS MARKET
  • FIGURE 4. TOP INVESTMENT POCKET IN COLD AND FLU SUPPLEMENTS MARKET
  • FIGURE 5. MODERATE BARGAINING POWER OF BUYERS
  • FIGURE 6. MODERATE BARGAINING POWER OF SUPPLIERS
  • FIGURE 7. MODERATE THREAT OF NEW ENTRANTS
  • FIGURE 8. LOW THREAT OF SUBSTITUTION
  • FIGURE 9. HIGH COMPETITIVE RIVALRY
  • FIGURE 10. OPPORTUNITIES, RESTRAINTS AND DRIVERS: GLOBALCOLD AND FLU SUPPLEMENTS MARKET
  • FIGURE 11. COLD AND FLU SUPPLEMENTS MARKET SEGMENTATION, BY BY PRODUCT TYPE
  • FIGURE 12. COLD AND FLU SUPPLEMENTS MARKET FOR NATURAL MOLECULES, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 13. COLD AND FLU SUPPLEMENTS MARKET FOR HERBAL EXTRACTS, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 14. COLD AND FLU SUPPLEMENTS MARKET FOR VITAMINS AND MINERALS, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 15. COLD AND FLU SUPPLEMENTS MARKET SEGMENTATION, BY BY END USER
  • FIGURE 16. COLD AND FLU SUPPLEMENTS MARKET FOR HOSPITALS, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 17. COLD AND FLU SUPPLEMENTS MARKET FOR AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 18. COLD AND FLU SUPPLEMENTS MARKET FOR OTHERS, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 19. TOP WINNING STRATEGIES, BY YEAR, 2022-2024*
  • FIGURE 20. TOP WINNING STRATEGIES, BY DEVELOPMENT, 2022-2024*
  • FIGURE 21. TOP WINNING STRATEGIES, BY COMPANY, 2022-2024*
  • FIGURE 22. PRODUCT MAPPING OF TOP 10 PLAYERS
  • FIGURE 23. COMPETITIVE DASHBOARD
  • FIGURE 24. COMPETITIVE HEATMAP: COLD AND FLU SUPPLEMENTS MARKET
  • FIGURE 25. TOP PLAYER POSITIONING, 2024
  • FIGURE 26. WAKUNAGA OF AMERICA CO., LTD.: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 27. WAKUNAGA OF AMERICA CO., LTD.: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 28. WAKUNAGA OF AMERICA CO., LTD.: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 29. NEUROBIOLOGIX INC.: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 30. NEUROBIOLOGIX INC.: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 31. NEUROBIOLOGIX INC.: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 32. THE VITAMIN SHOPPE: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 33. THE VITAMIN SHOPPE: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 34. THE VITAMIN SHOPPE: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 35. KLAIRE LABS: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 36. KLAIRE LABS: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 37. KLAIRE LABS: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 38. NORDIC NATURALS: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 39. NORDIC NATURALS: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 40. NORDIC NATURALS: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 41. HIMALAYA GLOBAL HOLDINGS LTD.: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 42. HIMALAYA GLOBAL HOLDINGS LTD.: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 43. HIMALAYA GLOBAL HOLDINGS LTD.: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 44. NATURE'S WAY PRODUCTS, LLC: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 45. NATURE'S WAY PRODUCTS, LLC: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 46. NATURE'S WAY PRODUCTS, LLC: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 47. FINEVINE, FLORA INC.: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 48. FINEVINE, FLORA INC.: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 49. FINEVINE, FLORA INC.: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 50. PFIZER INC.: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 51. PFIZER INC.: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 52. PFIZER INC.: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 53. GLAXOSMITHKLINE PLC: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 54. GLAXOSMITHKLINE PLC: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 55. GLAXOSMITHKLINE PLC: REVENUE SHARE, BY REGION, 2024 (%)

Purchase Full Report of
Cold and Flu Supplements Market

PURCHASE OPTIONS



* Taxes/Fees, If applicable will be added during checkout. All prices in USD.

Have a question ?

Need to add more ?

Avail up to 30% discount on subscription plans on


Avenue

© 2025 Allied Market Research. All Rights Reserved